Author

Sonam Puri

Moffitt Cancer CenterORCID 0000-0001-8068-5051Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Abbie S. IrelandiD· 1 shared Afshin DowlatiiD· 1 shared Andrew ElliottiD· 1 shared Anish ThomasiD· 1 shared Aria VaishnaviiD· 1 shared Benjamin E Hanna· 1 shared Benjamin L. WittiD· 1 shared Brandon MurphyiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abbie S. IrelandORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNaturePeer-reviewedSep 17, 2025

Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer

Abbie S. Ireland, Daniel A Xie, Sarah B. Hawgood…·Trudy G. Oliver

The paper identifies basal cells as the origin of neuroendocrine-tuft-like tumors in SCLC, revealing lineage plasticity and transcriptional states that mirror human cancer and normal cell injury responses.

48 citationstop 1%

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 4, 2025

BRAFV600E-Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling

Mélanie A. Dacheux, Mengting Wu, Michael T. Scherzer…·Aria Vaishnavi

This study shows that BRAFV600E-driven lung cancer requires ERBB receptor signaling via ligand-mediated activation, and combined inhibition of BRAFV600E and ERBB improves therapeutic outcomes.

DOI 10.1101/2025.05.04.652129

humanproteomics

𝕏 PostBluesky